Healthcare Attys Turn Attention To Material Adverse Change
By Yeji Jesse Lee · April 30, 2024, 10:26 PM EDT
Life sciences companies are focusing on a specific clause in M&A contracts to prevent unexpected disruptions from tanking deals, according to attorneys working on transactions in the healthcare industry....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login